Contrast Media

  • The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.

  • The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical University of Munich (TUM) has now demonstrated that the required quantity...

  • Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label update for Definity Vial for (Perflutren Lipid Microsphere) Injectable Suspension. The update removes the contraindication statement related to use in patients with a known or suspected cardiac...

  • Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be associated with chronic kidney disease, dialysis, kidney transplant or acute kidney injury, despite long-held fears to the contrary. The results of the largest controlled study of...

  • Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center, explains what is known about MRI contrast retention in the brain and other MRI safety concerns. He spoke to ITN at RSNA 2016.

PRAC, European Medicines Agency, gadolinium-based contrast agents, safety recommendations, brain MRI
News | Contrast Media | March 13, 2017

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new...

Technical University of Munich, Munich Compact Light Source, MuCLS, angiography, contrast agents

(a) Photograph of the sample in waterbath. (b) Empty image of full MuCLS beam. (c) Quasi-mono-energetic angiography image of a porcine heart acquired at the MuCLS, with iodine-based contrast agent injected into the left coronary artery. Visible are the left anterior descending artery (LAD) and the left circumflex artery (LCX). Image courtesy of the authors.

News | Angiography | March 10, 2017

The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some...

contrast media
Feature | Contrast Media Injectors | March 02, 2017 | By Jeff Zagoudis

With medical imaging use on the rise, contrast media use is expected to grow as well, according to a May 2016 report...

Lantheus Medical Imaging, Definity, FDA approval, label update, echocardiography, cardiac shunt contraindication
Technology | Contrast Media | February 02, 2017

Lantheus Medical Imaging Inc. announced U.S. Food and Drug Administration (FDA) approval of a label update for...

CT, computed tomography, IV contrast media, acute kidney injury risk, Annals of Emergency Medicine study

A new study in Annals of Emergency Medicine finds no association between intravenous contrast media used in computed tomography (CT) and kidney damage. Roughly 80 million doses of IV contrast media are given every year. Credit: American College of Emergency Physicians

News | Contrast Media | January 30, 2017

Intravenous contrast media (typically iohexol or iodixanol) used in computed tomography (CT) does not appear to be...

Videos | Magnetic Resonance Imaging (MRI) | December 12, 2016

Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of...

contrast media
News | Contrast Media | December 09, 2016

At the 2016 Annual Meeting of the Radiological Society of North America (RSNA 2016), Bracco Diagnostics Inc....

Bracco Diagnostics, CT Exprès 3-D Contrast Media Delivery System, RSNA 2016, computed tomography
Technology | Contrast Media Injectors | December 05, 2016

Bracco Diagnostics Inc. announced that CT Exprès — the first and only multi-dose, multi-patient, syringe-less...

GE Healthcare, Optison ultrasound contrast agent, FDA labeling change, cardiac shunts, intra-arterial injection
Technology | Contrast Media | October 04, 2016

GE Healthcare announced that the U.S. Food and Drug Administration (FDA) has approved a label change for the...

contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016

September 12, 2016 — Tiny microbubbles are being used to more effectively...

Toshiba, Aplio 500 Platinum ultrasound, International Contrast Ultrasound Society, ICUS, live case, contrast-enhanced
News | Ultrasound Imaging | September 07, 2016

September 7, 2016 — Toshiba America Medical Systems Inc.

gadolinium, ACR Manual on Contrast Media, update, FDA safety concerns
News | Contrast Media | July 12, 2016

July 12, 2016 — The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement...

MRI, gadolinium contrast, Parkinsonism, nervous system disorder, Blayne Welk, Western University
News | Contrast Media | July 05, 2016

July 5, 2016 — A study appearing in the July 5 issue of JAMA assessed the association between...

News | Magnetic Resonance Imaging (MRI) | June 01, 2016

June 1, 2016 — Alzeca Biosciences announced successful preliminary results for ADx, its novel, proprietary...

GlobalData, contrast media injectors market,
News | Contrast Media Injectors | May 03, 2016

The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion...

MR angiography, MRA, Bayer, Gadavist, gadobutrol injection, FDA approval, supra-aortic arteries
Technology | Contrast Media | April 29, 2016

Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for...

CTA, CT, contrast media injector, contrast injector, EmpowerCTA

Bracco's new EmpowerCTA+, designed for cardiac CT angiography exams.

Feature | Contrast Media Injectors | April 29, 2016 | Jeff Zagoudis

The biggest trend in contrast media injector technology today is one seen throughout all of healthcare — doing more...

Bracco NEXO
News | April 20, 2016

In the healthcare space, the capturing and documentation of data has become an integral part of operations.

News | Contrast Media | April 13, 2016

The global market for contrast media is set to rise from just over $4.3 billion in 2015 to over $6 billion by 2022,...

Duke University study, molecular lightbulbs, MRI imaging agent

Duke scientists have discovered a new class of inexpensive and long-lived molecular tags that enhance MRI signals by 10,000-fold. To activate the tags, the researchers mix them with a newly developed catalyst (center) and a special form of hydrogen (gray), converting them into long-lived magnetic resonance 'lightbulbs' that might be used to track disease metabolism in real time. Image courtesy of Thomas Theis, Duke University.

News | Magnetic Resonance Imaging (MRI) | March 28, 2016

Duke University researchers have taken a major step towards realizing a new form of magnetic resonance imaging (MRI...

Overlay Init